Universal antenatal screening for group B streptococcus may cause more harm than good

Abstract

Based on current evidence, routine screening for group B streptococcus colonisation in late pregnancy should not be introduced in the UK, as the potential harms of unnecessary treatment with antibiotics may outweigh the benefits, argue <b>Farah Seedat and colleagues</b>